Page 46 - Technology Development Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article REDWOOD CITY, Calif., April 19, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the appointment of Jon Shear to the newly created position of Vice President, Corporate Development, effective immediately.   "Jon is uniquely qualified for this new role and brings extensive insight and understanding of the medical technologies industry to Nevro," said D. Keith Grossman, Chairman, CEO and President of Nevro. "As a member...

To develop drugs that could help people recover after a stroke

UCLA March 4, 2021 Seventeen researchers at UCLA have been named recipients of awards from the 2020 UCLA Innovation Fund Biomedical Competition. These awards, up to $200,000 per project, support early stage research that lead to commercialization activities, which usually aren’t supported by basic research grants. As a result, researchers can develop their technologies to a point where the chances of success are greatly increased. Importantly, all awarded projects receive consultations from an outside industry and investor adviser panel, which provides technical and commercial feedback that...

UCLA MedTech/Courtesy of vfairs.com March 3, 2021 WHAT The UCLA Technology Development Group is hosting the ninth annual MedTech Partnering Conference. The event is dedicated to providing unique opportunities for inventors, researchers, scientists and medical and technology industry executives to establish relationships that will help further innovations in the fields of medicine, research and technology.  The 2021 gathering will be the first-ever virtual conference in the event’s history. Talks and panels will address topics including: Investor trends in the medtech industry Medical devi...

UCLA Health Dr. Rhonda Voskuhl Through a new collaboration with a South Korean pharmaceutical company, UCLA scientists will participate in the...